Compare RLAY & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | LGIH |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2013 |
| Metric | RLAY | LGIH |
|---|---|---|
| Price | $7.82 | $51.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | $16.00 | ★ $71.13 |
| AVG Volume (30 Days) | ★ 2.3M | 401.2K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.53 |
| Revenue | $8,355,000.00 | ★ $1,788,933,000.00 |
| Revenue This Year | $27.30 | N/A |
| Revenue Next Year | $7.43 | $15.95 |
| P/E Ratio | ★ N/A | $11.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.78 | $39.70 |
| 52 Week High | $8.36 | $112.97 |
| Indicator | RLAY | LGIH |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 59.56 |
| Support Level | $6.28 | $43.17 |
| Resistance Level | $8.36 | $53.64 |
| Average True Range (ATR) | 0.50 | 2.40 |
| MACD | 0.14 | 0.87 |
| Stochastic Oscillator | 76.56 | 81.28 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.